Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow InternationalHKSE:00239 -1.68%80 Days Inventory is 135.77 as of Dec. 2025, which is 16% below its 10-year median of 161.71. GuruFocus rates HKSE:00239 with a GF Score™ of 80/100 and a GF Value™ of HK$2.17 (Fairly Valued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Pak Fah Yeow International ranks worse than 51.08% on this metric.
The historical rank and industry rank for Pak Fah Yeow International's Days Inventory or its related term are showing as below:
HKSE:00239'
s Days Inventory Range Over the Past 10 Years
Min: 126.91 Med: 161.71 Max: 262.71
Current: 167.84
During the past 13 years, Pak Fah Yeow International's highest Days Inventory was 262.71. The lowest was 126.91. And the median was 161.71.
HKSE:00239's Days Inventory is ranked worse than 51.08% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs HKSE:00239: 167.84
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pak Fah Yeow International's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pak Fah Yeow International's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
Pak Fah Yeow International (HKSE:00239) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pak Fah Yeow International's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pak Fah Yeow International's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pak Fah Yeow International Days Inventory Related Terms
Pak Fah Yeow International Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pak Fah Yeow International (HKSE:00239) has a Days Inventory of 135.77 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pak Fah Yeow International and its competitors. This is 16% below median its historical median of 161.71. Over the past decade, Pak Fah Yeow International's Days Inventory has ranged from 126.91 to 262.71. According to the industry distribution chart, Pak Fah Yeow International ranks #471 out of 922 companies in the Drug Manufacturers industry, placing it in the top 51.1%.
Is Pak Fah Yeow International's Days Inventory too high?
Pak Fah Yeow International's current Days Inventory of 135.77 is 16% below median its 10-year median of 161.71. Over the past 10 years, this metric has ranged from a low of 126.91 to a high of 262.71. The Drug Manufacturers industry median Days Inventory is 165.01. Pak Fah Yeow International's value of 135.77 is 17.7% below this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #471 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #471 out of 922 companies for Days Inventory. This places Pak Fah Yeow International in the lower half of its industry. The industry median Days Inventory is 165.01. Pak Fah Yeow International's value of 135.77 is 17.7% below this benchmark. Historically, Pak Fah Yeow International's own Days Inventory has ranged from 126.91 to 262.71 over the past decade. While the company's 10-year median is 161.71 vs. the industry median of 165.01, Pak Fah Yeow International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current Days Inventory of 135.77 is 17.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current Days Inventory is 135.77, which is 16% below median its own 10-year median of 161.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.34 — trading 7.6% above its estimated fair value. The current Days Inventory is 135.77, which is 16% below median its 10-year median of 161.71 and 17.7% below the Drug Manufacturers industry median of 165.01. Pak Fah Yeow International's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current Days Inventory is 135.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.34 is trading 7.6% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
Days Inventory: 135.77 (16% below median its 10-year median of 161.71)
GF Value™: HK$2.17 vs. price of HK$2.34 (7.6% above fair value)
Industry Position: 17.7% below the Drug Manufacturers median (#471 of 922)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
